Skip to main content
- Smoker, male, 40s, small dark ulcers on digits of hand, small ulcer on toe, dorsalis pedis pulses diminished bilaterally - Thromboangiitis obliterans
- HFpEF no specific therapy clearly associated with survival benefit
- AFib+TIA+RHD - treatment elective cardioversion, warfarin with target INR of 2.5 for 3 weeks before cardioversion and continued for 4 weeks after cardioversion
- There is no known treatment to prevent allograft vasculopathy
- Flecainide is appropriate to prevents recurrent Afib with non structural heart disease
- Final common pathway of platelet aggregation is mediated through glycoprotein (GP) IIb/IIIa receptor
- Resistant hypertension is defined persistent hypertension despite three antihypertensive agents at or near maximal dose, of different classes including a diuretic
- Percutaneous VSD closure is for type 4/muscular